STAT3 and neoplasm: A promising strategy could be the inhibition of specific CSC-generating and CSC-expanding pathways, such as the Wnt, Shh, JAK/STAT3 and PI3/AKT signaling pathways, which regulate thyroid CSC self-renewal and tumor growth.